Skip to main content

Nanomedicine for Deep-Tissue High-Resolution Bio-Imaging and Non-Invasive Therapy

Cover image for Research Topic "Nanomedicine for Deep-Tissue High-Resolution Bio-Imaging and Non-Invasive Therapy"
187kviews
Editorial02 September 2020
Editorial: Nanomedicine for Deep-Tissue High-Resolution Bio-Imaging and Non-invasive Therapy

The interdisciplinary research of nanotechnology and biomedical application yields an emerging field of nanomedicine, which seeks to develop functional agents for in vivo bioimaging (diagnosis), advanced drug delivery, and innovative therapy. It's our great pleasure to have this opportunity to include 16 articles in this Research Topic, either indepth reviews or original research articles.Nanomedicine for bioimaging is a contrast agent modified with functional moieties to target a specific part-of-interest, such as cancer cells or tumor tissues. Valuable in situ diagnostic information can be obtained only when both the bioimaging nanomedicine and the imaging instrumentation are communicating. Optical bioimaging techniques demonstrate advantages of low-cost, portability, and non-invasiveness. Yang et al. surveyed recent advances in the development of optically active nanomaterials, including gold, porous silicon, up-conversion, semiconductor nanocrystal, and carbon-based nanomaterials, along with mainstream optical bioimaging modalities, such as fluorescence, luminescence, surface enhanced Raman scattering (SERS) and photoacoustic (PA). Among them, fluorescence bioimaging holds great promise for the deep-tissue imaging but is hindered by the shallow imaging depth. Near infrared (NIR) fluorescent lifetime-based imaging can suppress the scattering and self-fluorescence noise and obtain the quantitatively functional information. Lian et al. (Lian et al., 2019) overviewed the progresses of contrast agent's development (including organic dyes and nanomaterials) and the implementation of this imaging method. Cao et al. (Cao et al., 2020) presented a detailed review on the fluorescent nanoparticles (NPs) working in near infrared wavelength ranging from nm to 1300 nm, which is called the NIR II window and in the range of which light is less absorbed by the tissue than in the visible and near infrared range below 1000 nm. The authors summarized the characteristics of several typical nanomaterials including single-walled carbon nanotubes, Ag2S quantum dots, rare earth NPs, and organic fluorescent dye NPs. More recently, new bioimaging techniques that hybridize ultrasound and optics have attracted increasing attention, and deep-tissue highresolution bioimaging has been conceived in a number of proof-of-concept studies (Pei and Wei, 2019).The other idea to decrease the scattering and autofluorescence in the optical imaging is to use luminescent agents because the strong excitation light is eliminated. Li et al. summarized the progress on the development of NIR self-illuminating agents and the design principles. They also discussed the current challenges and future developments. Le et al. (Le et al., 2020) focused on the topic of chemiluminescence for optical imaging. The nanomaterials for bioluminescence and ultrasound enhanced chemiluminescence imaging are reviewed and the future direction is discussed.Subsequently, a secondary nanomedicine that contains a therapeutic or regenerative drug will be deployed to the part-of-interest, and the drug release could be triggered precisely by non-invasive means, such as ultrasound, optics, magnet, or heat. Photothermal conversion agents triggers thermal therapy under the irradiation of the laser energy. Antibody (anti-protein A IgG) functionalized MoS2 nanosheets (MPPI NSs) developed by Zhang et al. (Zhang et al., 2019b) were demonstrated to be effective for the treatment of S. aureus focal infection on a mouse model. The MPPI NSs can specifically target to the bacterial and showed inactivation efficiency larger than 99.99% in both biofilms and in infected tissues, with minimal damage to mammalian cells. Meanwhile, the high extinction coefficient of MoS2 nanosheets in the NIR region provides the ability for real-time photoacoustic imaging. However, as mentioned previously, optical imaging and therapy usually suffer from low tissue penetration due to the absorption of the light by the tissue. For deep-seated tumor such as hepatocellular carcinoma, Zhou et al. (Zhou et al., 2019) labeled radionuclides 125 I to the AA98 monoclonal antibody ( 125 I-AA98 mAb) against CD146, a biomarker for angiogenesis with high expression in hepatocellular carcinoma cells. After intratumoral injection in a mouse model, the 125 I-AA98 mAb not only inhibited the early angiogenic process, but also induced apoptosis of the cancer cells, achieving higher therapeutic efficacy than treatment by free 125 I. The tumor response to the targeted therapy were monitored by single-photon emission computerized tomography (SPECT) with high sensitivity and tissue penetration. To overcome the limitation of penetration depth of light, ultrasound can be used for both imaging and therapy. In the research by Vighetto et al. (Vighetto et al., 2019), the generation of reactive oxygen species (ROS) by single-crystalline zinc oxide (ZnO) NPs and ultrasound were studied. The cavitation effect of gas nanobubbles under ultrasound were responsible for the generation of hydroxyl and superoxide anions, which causing ROS-mediated apoptosis or necrosis of cells. Notably, the generated acoustic signal can be monitored by B-mode ultrasound imaging, suggesting the capability of ZnO NPs as an ultrasound aided theranostic agent. Interestingly, the health effects of non-invasive therapy on human should be carefully studied. Song et al. (Song et al., 2019) demonstrated that whole body vibration (WBV), a non-invasive physical therapy, significantly increased the CD4 and CD25 positive lymphocytes as well as the population of Treg cells in the spleen. Therefore, the contents of a variety of bacteria changed, such as Lactobacillus animalis in mice, and Lactobacillus paraplantarum and Lactobacillus sanfranciscensis in human.In a best-case scenario, the therapy or regeneration process can be monitored real-time through the bioimaging. The interactive cooperation between these two procedures will provide accurate and effective treatment for human diseases. Kuriakose et al. (Kuriakose et al., 2019) developed a new biodegradable photoluminescent polylactones-co-poly (lactic-co-glycolic acid) copolymers (BPLP-PLGA) as nanocarriers for protein delivery. These NPs displayed superior stability (2 days) in physiological conditions, tunable release kinetics and fluorescence emission, compatibility with endothelial cells, and good hemocompatibility. Thereby, the BPLP-PLGA NPs have potential to serve as optical contrast agents and nanocarriers of the drugs for cardiovascular diseases. Tian et al.'s mini-review (Tian et al., 2019) emphasizes some recent advances of gold nanomaterials-based photothermal imaging (PTI), SERS imaging, and PA imaging-guided in vivo therapy in NIR region (>800 nm).Hu et al. examined the potential value of multimodality gadoliniumbased NPs (AGuIX) for non-invasive theranostic MRI-guided radiotherapy in hepatocellular carcinoma (HCC). The AGuIX provide better detection of tumors in imaging, and precise identification for accurate MRI-guided radiotherapy; meanwhile, the heavy elements in this novel nanoparticle can enhance radiosensitizing effect by irradiation dose deposition. We are extremely excited to notice that artificial intelligent (AI) has been pushing the development of nanomedicines. For instance, with the rapid development of nanotechnology in the field of biomedicine, artificial blood or blood substitute has shown promising features for the emergency treatment of BDDs. Chemotherapy, bone marrow transplantation, and stem cell therapy have been used to treat blood disorder diseases (BDDs). However, the cure rates are still low due to the availability of the right type of bone marrow and the likelihood of recurrence and infection. Zhang et al. (Zhang et al., 2019a) surveyed recent advances in the development of artificial blood components: gas carrier components (erythrocyte substitutes), immune response components (white blood cell substitutes), and hemostasis-responsive components (platelet substitutes). Platelet-inspired nanomedicines for cancer treatment were also discussed.Wang et al. summarized the applications of nanozymes for disease imaging and detection to explore their potential application in disease diagnosis and precision medicine. Compared to natural enzymes, nanozymes exhibit the unique advantages including high catalytic activity, low cost, high stability, easy mass production, and tunable activity. In addition, as a new type of artificial enzymes, nanozymes not only have the enzyme-like catalytic activity, but also exhibit the unique physicochemical properties of nanomaterials, such as photothermal properties, superparamagnetism, and fluorescence, etc. Despite the remarkable advantages of nanozymes, there remains plenty of limitations while put nanozymes into practical clinical application, such as poor dispersibility, easy sedimentation after surface modification, limited catalytic types, poor substrate selectivity, and potential nanotoxicity.Compared to detecting proteins secreted by tumors, detecting secreted miRNAs has become more attractive for monitoring tumor progression. Ma et al. (Ma et al., 2019) designed an artificial intelligent signal amplification (AISA) system including doublestranded SQ (S, signal strand; Q, quencher strand) and FP (F, fuel strand; P, protect strand) according to thermodynamics principle for sensitive detection of miRNA in vitro and in vivo. The design features conceiving signal amplification and preventing from in vivo degradation and complications. Based on this detection system, the precancerous lesions of liver cancer were diagnosed and reconstructed.The last but not the least, we should always keep in mind to take into consideration of the potential nanotoxicity of nanomedicines, which may fail the clinical trial due to severe side effects. To this end, Dong et al. (Dong et al., 2020) investigated the candidate fate of acid-oxidized single-walled carbon nanotubes (SWNCTs) in nonactivated primary mouse peritoneal macrophages (PMQ). All data showed that exocytosis, uptake, biodegradation and sustainable retention of SWCNTs co-exist in primary macrophages.In summary, we are pleased to witness such landmark progresses in the development of nanomedicines that are aiming to provide real-time bioimaging-guided non-invasive therapy for human diseases, along with the integration of artificial intelligence technology. The findings included in this Research Topic will open the avenue for brighter ideas in future "Smart Nanomedicines" development. During this pandemic season of 2020, we shall keep hope and trust in science, only by which we can overcome the challenge from the COVID-19.AUTHOR CONTRIBUTIONS YG, YP, and M-YW wrote and edited the manuscript.Supported by National Natural Science Foundation of China (81601608).

2,489 views

MINI REVIEW
6 February 2020
Nanozymes: A New Disease Imaging Strategy
Peixia Wang, 3 more and Minmin Liang

21,250 views

104 citations

REVIEW
30 January 2020
Recent Progress in NIR-II Contrast Agent for Biological Imaging
Jie Cao, 5 more and Huanghao Yang
Recent Progress in NIR-II Contrast Agent for Biological Imaging
Fluorescence imaging technology has gradually become a new and promising tool for in vivo visualization detection. Because it can provide real-time sub-cellular resolution imaging results, it can be widely used in the field of biological detection and medical detection and treatment. However, due to the limited imaging depth (1-2 mm) and self-fluorescence background of tissue emitted in the visible region (400-700 nm), it fails to reveal biological complexity in deep tissues. The traditional near infrared wavelength (NIR-I, 700-950 nm) is considered as the first biological window, because it reduces the NIR absorption and scattering from blood and water in organisms. NIR fluorescence bioimaging’s penetration is larger than that of visible light. In fact, NIR-I fluorescence bioimaging is still interfered by tissue autofluorescence (background noise), and the existence of photon scattering, which limits the depth of tissue penetration. Recent experimental and simulation results show that the signal-to-noise ratio (SNR) of bioimaging can be significantly improved at the second region near infrared (NIR-II, 1000-1700 nm), also known as the second biological window. NIR-II bioimaging is able to explore deep-tissues information in the range of centimeter, and to obtain micron-level resolution at the millimeter depth, which surpass the performance of NIR-I fluorescence imaging. The key of fluorescence bioimaging is to achieve highly selective imaging thanks to the functional/targeting contrast agent (probe). However, the progress of NIR-II probes is very limited. To date, there only are few reports about NIR-II fluorescence probes, such as carbon nanotubes, Ag2S quantum dots and organic small molecular dyes. In this paper, we surveyed the development of NIR-II imaging contrast agents and their application in cancer imaging, medical detection, vascular bioimaging and cancer diagnosis. In addition, the hotspots and challenges of NIR-II bioimaging are discussed. It is expected that our findings will lay a foundation for further theoretical research and practical application of NIR-II bioimaging, as well as the inspiration of new ideas in this field.

31,161 views

326 citations

ORIGINAL RESEARCH
29 November 2019
Whole Body Vibration Triggers a Change in the Mutual Shaping State of Intestinal Microbiota and Body's Immunity
Ning Song, 9 more and Shili Liu

23,698 views

23 citations

MINI REVIEW
5 December 2019
Gold Nanomaterials for Imaging-Guided Near-Infrared in vivo Cancer Therapy
Yuanyuan Tian, 1 more and Lianhui Wang

8,357 views

39 citations

ORIGINAL RESEARCH
27 November 2019
Gadolinium-Based Nanoparticles for Theranostic MRI-Guided Radiosensitization in Hepatocellular Carcinoma
Pengcheng Hu, 5 more and Dengfeng Cheng

5,284 views

41 citations

ORIGINAL RESEARCH
26 November 2019
The Synergistic Effect of Nanocrystals Combined With Ultrasound in the Generation of Reactive Oxygen Species for Biomedical Applications
Veronica Vighetto, 5 more and Valentina Cauda

5,930 views

41 citations

REVIEW
15 November 2019
Optically Active Nanomaterials for Bioimaging and Targeted Therapy
Yu Yang, 3 more and Xinxin Li

10,554 views

68 citations

ORIGINAL RESEARCH
10 September 2019
Antibody-Functionalized MoS2 Nanosheets for Targeted Photothermal Therapy of Staphylococcus aureus Focal Infection
Yuqian Zhang, 7 more and Lianhui Wang

6,593 views

47 citations

ORIGINAL RESEARCH
14 November 2019
Treatment of Hepatocellular Carcinoma by Intratumoral Injection of 125I-AA98 mAb and Its Efficacy Assessments by Molecular Imaging
Jun Zhou, 8 more and Hongcheng Shi

5,561 views

7 citations

ORIGINAL RESEARCH
21 November 2019
An Artificial Intelligent Signal Amplification System for in vivo Detection of miRNA
Xibo Ma, 12 more and Jie Tian

4,847 views

6 citations